Company / Operating Margin
AIM ImmunoTech Inc. Operating Margin History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Margin
-13254.6%
FY2025
5-year range
-15800.0% / -9295.7%
FY2021-FY2025
Trend
+16.1%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Margin returned to growth in FY2025 after 3 years of decline, reaching -13254.6%.
Based on SEC 10-K filings.
-13254.6% in FY2025 with a 5-year CAGR of -3958.8%.
Improved from -14129.8% to -13254.6% over the past 2 years.
Operating Margin over time
Growth rates
- 3-Year Change
- +699.5pp
- 5-Year Change
- -3958.8pp
- 10-Year Change
- -
Key checks
Key Insights
- In FY2025, operating margin increased 16.1% year-over-year.
- Peak operating margin was recorded in FY2018.
- Lowest operating margin in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score -71.45 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -13254.6% | +16.1% |
| FY2024 | -15800.0% | -11.8% |
| FY2023 | -14129.8% | -1.3% |
| FY2022 | -13954.1% | -50.1% |
| FY2021 | -9295.7% | +0.0% |
| FY2020 | -9295.7% | -4.6% |
| FY2019 | -8887.9% | -183.7% |
| FY2018 | -3132.4% | +75.0% |
| FY2017 | -12518.8% | +16.6% |
| FY2016 | -15004.3% | -19.9% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026